EIN 82-1199380

Global Coalition for Adaptive Research

IRS 501(c) type
Num. employees
Year formed
Most recent tax filings
NTEE code, primary
Global Coalition for Adaptive Research accelerates discovery and development of cures for rare and deadly diseases through clinical trial platforms.
Total revenues
Total expenses
Total assets
Num. employees

Program areas at Global Coalition for Adaptive Research

Gbm agile (glioblastoma Adaptive Global innovative learning environment) is uniquely designed as a long-standing platform with the ability to test multiple therapies at the same time against a common control (or standard of care). The purpose is to evaluate multiple investigational treatments for either newly diagnosed or recurrent glioblastoma to determine if any of these study treatment(s) improve overall survival as compared to standard treatments.
Consulting, in-development, and shorter duration programs in other rare and deadly disease areas.
The objective of remap-covid is to reduce mortality and morbidity in patients hospitalized with covid-19 infection by quickly generating new evidence on available and novel treatments. Through partnerships with academia, industry and multiple healthcare systems, gcar is sponsoring remap-covid in the us with the university of pittsburgh serving as the us regional coordinating center for remap-cap.

Grants made by Global Coalition for Adaptive Research

GranteeGrant descriptionAmount
National Brain Tumor Society (NBTS)General Assistance$250,000

Who funds Global Coalition for Adaptive Research

Grants from foundations and other nonprofits
University of PittsburghResearch- Subcontract$566,718
AmazonSmile FoundationGeneral Support$152

Personnel at Global Coalition for Adaptive Research

David F. Arons, J.D.Chief Executive Officer, National Brain Tumor Society
David R. ParkinsonPresident, Chief Executive Officer and Director, Essa
Laurence James-NeilChief Executive Officer, Ziopharm Oncology
Max Wallace, J.D.Chief Executive Officer, Accelerate Brain Cancer Cure
Meredith BuxtonChief Executive Officer and President$700,000
...and 37 more key personnel

Financials for Global Coalition for Adaptive Research

RevenuesFYE 12/2022
Total grants, contributions, etc.$543,271
Program services$34,345,933
Investment income and dividends$483,944
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$0
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$35,373,148

Form 990s for Global Coalition for Adaptive Research

Fiscal year endingDate received by IRSFormPDF link
2022-122023-05-15990View PDF
2020-122021-11-15990View PDF
2019-122021-04-02990View PDF
2018-122020-02-06990View PDF
2017-122018-11-15990EZView PDF
Data update history
July 25, 2023
Posted financials
Added Form 990 for fiscal year 2020
July 20, 2023
Posted financials
Added Form 990 for fiscal year 2022
July 3, 2023
Updated personnel
Identified 6 new personnel
June 29, 2023
Used new vendors
Identified 2 new vendors, including , and
June 26, 2023
Received grants
Identified 1 new grant, including a grant for $566,718 from University of Pittsburgh
Nonprofit Types
Grantmaking organizationsDisease research fundraisersMedical research organizationsCharities
Conducts researchTax deductible donations
General information
700 Larkspur Landing Cir 199
Larkspur, CA 94939
Metro area
San Francisco-Oakland-Berkeley, CA
Website URL
(617) 299-6471
IRS details
Fiscal year end
Taxreturn type
Form 990
Year formed
Eligible to receive tax-deductible contributions (Pub 78)
NTEE code, primary
H30: Cancer Research
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Free account sign-up

Want updates when Global Coalition for Adaptive Research has new information, or want to find more organizations like Global Coalition for Adaptive Research?

Create free Cause IQ account